|


CIGA Healthcare Newswire
NEWS
June 2009
Visit to Cypriot distributor showed major progress in the market.
Meningitis test launched in the UK and Ireland.
First orders for the Danish market.
May 2009
Visit to Qatar to Futuralia exhibition, tests exhibited at Bulmedica in Bulgaria and first Meningitis Packs delivered.
CIGA on shortlist for Irish News Workplace and Employment Awards on 18th June. We are joined by Thomas a German student to explore export markets.
April 2009
First orders shipped to Cyprus, vist by our Scandinavian partner agreement for Canadian and Scandinavian distribution. We are joined by Chris and Kelly in Marketing and Sales.
March 2009
Award of major contract from Boots PLC, first orders shipped to Bulgaria.
Appointment of distributor for Cyprus and Greece.
February 2009
Discussions with the Meningitis Research Foundation have led to the design of a new meningitis
test pack planned for April, the Foundation will provide a free phone 24 hour help line.
January 2009
During a UK Government Mission to Dubai a distribution agreement was signed for the GCC comprising Saudi
Arabia, Kuwait, Bahrain, Qatar, Oman and the United Arab Emirates
December 2008
Agreement has been reached with a distributor in Bulgaria who will also cover neighbouring Serbia, Moldova, and Kosovo.
November 2008
Extensive sales missions to the Middle East resulted in a very high level of enquiries
and companies seeking to distribute the SURESIGN range in the region. Negotiations to appoint
a distributor will be finalised in the near future.
Research in Canada into regulatory requirements and the market resulted in negotiations
with an Ontario company to distribute the SURESIGN Range across Canada.
A visit to Medica the world's largest Medical exhibition resulted in meetings with current
and new suppliers with several additions to the SURESIGN range likely in 2009 .
October 2008 - CIGA wins prestigious Marketing Award.
CIGA was awarded the Professor William Clarke Award for the Best Performing
Young Marketing Business at the 10th annual Chartered Institute of Marketing
Awards at a glittering ceremony in Belfast.
CIGA won the Business Growth Award at the Ballymena Excellence in Business Awards
CIGA exhibits at Pharmacy Show
CIGA attended the Pharmacy Show for the UK launch of the their new Health
Test Centre. The centre was very well received by the visiting pharmacists.
Several international distributors were also interested in the SURESIGN® range.
September 2008 - CIGA exhibit new display stand at the SANA show in Bologna Italy in
partnership with their Italian distributor. The stand was very well received
and several large retailers have expressed interest in stocking the SURESIGN® brand.
A sales mission to Germany to meet several potential distributors was very
successful and it is hoped to appoint a distributor in the near future.
August 2008 - New retail display stands finalised for launch at the Sana Show in Italy in September and the UK Pharmacy Show in October.
July 2008 - Launch of products in Ireland met with immediate success with several listings in major outlets.
|
UK Small Industrial Company of the Year
Some
of our Friends


|
CIGA
Healthcare
Every
15 Seconds Someone Uses a CIGA Test
CIGA Healthcare
is a fast growing dynamic company that specializes in the Rapid
Self Test Health Diagnostics sector and is leading developments
in this rapidly emerging new OTC market. Since it was
established the company has grown rapidly and now supplies tests
to retailers in the UK such as ASDA, Boots, Tesco Morrisons,
Waitrose and Sainsbury’s.
CIGA has
distributors across Europe who can supply retailers the
opportunity to have carefully selected range of fast selling
Self Test Products. These can be promoted as an integrated range
to their customers and provide coverage of all age demographics
from 0 – 100 under one brand
SURESIGN®.
As customers realize that they have the prime responsibility for
their health they want to be able to monitor not only their own
health but also their families’ health on a regular basis.
Diagnostic Self Tests allow them to ensure that many potential
health problems are caught as early as possible and can be
treated to avoid long term problems.
CIGA’s SURESIGN®
range of Self Tests is growing quickly to meet the new demands
of this market. It is forecast the UK Self Test sector will
increase in value by more than 100% over the next 5 years,
approaching £150,000,000. The market in the rest of Europe is
also expected to experience similar strong growth with sales in
excess of £200,000,000.
CIGA’s tests and equipment range from fertility to
heart health to blood pressure monitoring and they are being
added to on a regular basis as demands from the market are
identified. CIGA’s
SURESIGN® brand is sold in over 5,000 multiple,
pharmacy, grocery and general retail outlets across the UK and
also in a large number of other countries including Saudi
Arabia, Ireland, Italy, Bulgaria, Denmark, Norway, Hungary,
Benelux and many more. All tests and equipment are fully
compliant with European-wide CE marking regulations and are
assessed by independent bodies appointed by The Medicines and
Health Regulatory Agency (MHRA) to ensure they are of the
highest standard and our quality rating exceeds 99.998%.
CIGA's success
has been recognized by several prestigious awards including the 'UK
Small Industrial Company of the Year' in the Best of
British Awards sponsored by the Sunday Times, AMEC and the Work
Foundation and ‘Young
Marketing Business of the Year’ by the UK
Chartered Institute of Marketing.
Latest News
Daily Mail selects SURESIGN Menopause test as a top 10 woman's product
The Daily Mail one of the UK's leading daily newspapers has selected the SURESIGN Menopause test as one of the top ten women's health products in 2009. This shows the continued popularity of the SURESIGN brand in the UK where more and more people are turning to
SURESIGN.
Click
here to read more...
Awards CIGA Healthcare
is an award-winning company. Read about recognition won by
CIGA
here...

Ballymena Business Centre -
CIGA Packaging and Distribution
updated
July 28, 2009
|
|